TARSUS PHARMACEUTICALS, INC. (TARS) Capital expenditures 2019–2025
TARSUS PHARMACEUTICALS, INC. (TARS) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$9.9MFY2025 · since FY2019: $175,000 → $9.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $9.9M | +529.2% |
| FY2024 | $1.6M | +4.3% |
| FY2023 | $1.5M | +196.8% |
| FY2022 | $506,000 | -13.7% |
| FY2021 | $586,000 | +28.5% |
| FY2020 | $456,000 | +160.6% |
| FY2019 | $175,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice